- Home
- CANF vs SRFM Comparison
CANF vs SRFM Comparison
Compare CANF & SRFM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CANF | SRFM |
|---|---|---|
| Founded | 1994 | 2011 |
| Country | Israel | United States |
| Employees | 5 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Transportation Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.7M | 123.3M |
| IPO Year | 2011 | 2023 |
Fundamental Metrics
Financial Performance| Metric | CANF | SRFM |
|---|---|---|
| Price | $3.63 | $1.47 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 2 | 3 |
| Target Price | ★ $9,750.00 | $3.75 |
| AVG Volume (30 Days) | 634.9K | ★ 1.4M |
| Earning Date | 01-01-0001 | 06-24-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 45.69 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $106,557,000.00 |
| Revenue This Year | $461.72 | N/A |
| Revenue Next Year | $290,391.28 | $8.40 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.17 | $1.77 |
| 52 Week High | $10.40 | $9.35 |
Technical Indicators
Market Signals| Indicator | CANF | SRFM |
|---|---|---|
| Relative Strength Index (RSI) | 40.57 | 27.17 |
| Support Level | $0.60 | N/A |
| Resistance Level | $4.74 | $2.21 |
| Average True Range (ATR) | 0.71 | 0.14 |
| MACD | -0.19 | -0.02 |
| Stochastic Oscillator | 1.16 | 0.70 |
Price Performance
Historical ComparisonAbout CANF Can-Fite Biopharma Ltd Sponsored ADR (Israel)
Can Fite Biopharma Ltd is a clinical-stage biopharmaceutical company. The company focuses on developing orally bioavailable small-molecule drugs targeting the A3 adenosine receptor for treating cancer, inflammatory diseases, liver disorders, and related conditions. It has a pipeline of proprietary drug candidates in Phase II and Phase III clinical development. The company's platform targets the A3 adenosine receptor (A3AR), which is more expressed in inflammatory and cancerous cells than in normal cells. Its pipeline drugs include Namodenoson, Piclidenoson, CF602, and Cannabinoids.
About SRFM Surf Air Mobility Inc.
Surf Air Mobility Inc provides a regional air mobility platform to connect communities sustainably. The company is an electric aviation and air travel company expanding the category of regional air travel and reinventing flying through electrification. The company is building a regional air mobility ecosystem to sustainably connect the world's communities. It generates revenue through air mobility services.